Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat

Physiology and Behavior

Volumn 82, Issue 5, 2004, Pages 863-869

  Chambers, Adam P ^a   Sharkey, Keith A ^a   Koopmans, Henry S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anandamide; Body weight; Cannabinoids; Food intake; VDM 11

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; METHANANDAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

EID: 4644307556     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2004.07.004     Document Type: Article

References (37)

1. R.G. Pertwee, and R.A. Ross Cannabinoid receptors and their ligands Prostaglands Leukot. Essent. Fatty Acids 66 2002 101 121
2. D. Piomelli The molecular logic of endocannabinoid signaling Nat. Neurosci. 4 2003 873 884
3. R.W. Foltin, J.V. Brady, and M.W. Fischman Behavioral analysis of marijuana effects on food intake in humans Pharmacol. Biochem. Behav. 25 1986 577 582
4. J.E. Koch Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets Pharmacol. Biochem. Behav. 68 2001 539 543
5. 9-THC and anandamide Physiol. Behav. 76 2002 241 250
6. C.M. Williams, and T.C. Kirkham Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors Psychopharmacology (Berl) 143 1999 315 317
7. R. Gomez, M. Navarro, B. Ferrer, J.M. Trigo, A. Bilbao, and I. Del Arco A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding J. Neurosci. 22 2002 9612 9617
8. T.C. Kirkham, C.M. Williams, F. Fezza, and V. Di Marzo Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol Br. J. Pharmacol. 136 2002 550 557
9. A.L. Hildebrandt, D.M. Kelly-Sullivan, and S.C. Black Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice Eur. J. Pharmacol. 462 2003 125 132
10. S.P. Vickers, L.J. Webster, A. Wyatt, C.T. Dourish, and G.A. Kennett Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats Psychopharmacology (Berl) 167 2003 103 111
11. R.Z. Chen, R.C. Huang, C. Shen, D.J. MacNeil, and T.M. Fong Synergistic effects of cannabinoid inverse agonist AM 251 and opioid antagonist nalmefene on food intake in mice Brain Res. 999 2004 227 230
12. C.J. Hillard, and A. Jarrahian The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes Chem. Phys. Lipids 108 2000 123 134
13. S.T. Glaser, N.A. Abumrad, F. Fatade, M. Kaczocha, K.M. Studholme, and D.G. Deutsch Evidence against the presence of an anandamide transporter Proc. Natl. Acad. Sci. U. S. A. 100 2003 4269 4274
14. L. De Petrocellis, T. Bisogno, J.B. Davis, R.G. Pertwee, and V. Di Marzo Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity FEBS Lett. 483 2000 52 56
15. T. Bisogno, L. De Petrocellis, and V. Di Marzo Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications Curr. Pharm. Des. 8 2002 533 547
16. A. Ligresti, E. Morera, M.M. van der Stelt, K. Monory, B. Lutz, and G. Ortar Further evidence for the existence of a specific process for the membrane transport of anandamide J. Biochem. 380 2004 265 272
17. D. Cota, G. Marsicano, B. Lutz, V. Vicennati, G.K. Stalla, and R. Pasquali Endogenous cannabinoid system as a modulator of food intake Int. J. Obes. Relat. Metab. Disord. 27 2003 289 301
18. A. Giuffrida, F. Rodriguez de Fonseca, F. Nava, P. Loubet-Lescoulie, and D. Piomelli Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404 Eur. J. Pharmacol. 408 2000 161 168
19. E. de Lago, A. Ligresti, G. Ortar, E. Morera, A. Cabranes, and G. Pryce In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake Eur. J. Pharmacol. 484 2004 249 257
20. S.C. Benoit, E.L. Air, K. Wilmer, P. Messerschimidt, K.M.B. Hodge, and M.B. Jones Two novel paradigms for the simultaneous assessment of conditioned taste aversion and food intake effects of anorexic agents Physiol. Behav. 79 2003 761 766
21. G. Columbo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G.L. Gessa Appetite suppression and weight loss after the cannabinoid antagonist SR 141716 Life Sci. 63 1998 PL113 PL117
22. http://en.sanofi-synthelabo.com/rd/p_research.asp
23. N.A. Darmani Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A Neuropsychopharmacology 24 2001 198 203
24. M.D. Van Sickle, L.D. Oland, W. Ho, C.J. Hillard, K. Mackie, and J.S. Davison Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret Gastroenterology 121 2001 767 774
25. F. Massa, G. Marsicano, H. Hermann, A. Cannich, K. Monory, and B.F. Cravatt The endogenous cannabinoid system protects against colonic inflammation J. Clin. Invest. 113 2004 1202 1209
26. M.J. Wallace, R.E. Blair, K.W. Falenski, B.R. Martin, and R.J. De Lorenzo The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy J. Pharmacol. Exp. Ther. 307 2003 129 137
27. C. Ravinet Trillou, M. Arnone, C. Delgorge, N. Gonalons, P. Keane, and J.P. Maffrand Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice Am. J. Physiol., Regul. Integr. Comp. Physiol. 284 2003 R345 R353
28. S.J. Gatley, A.N. Gifford, N.D. Volkow, R. Lan, and A. Makriyannis 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors Eur. J. Pharmacol. 307 1996 331 338
29. M. Bensaid, M. Gary-Bobo, A. Esclangon, J.P. Maffrand, G. Le Fur, and F. Oury-Donat The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in culture adipocyte Cell. Mol. Pharmacol. 63 2003 908 914
30. G. Burdyga, S. Lal, A. Varro, R. Dimaline, D.G. Thompson, and G.J. Dockray Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin J. Neurosci. 24 2004 2708 2715
31. V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Batkai, and Z. Jarai Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825
32. J.A. Harrold, J.C. Elliott, P.J. King, P.S. Widdowson, and G. Williams Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res. 952 2002 232 238
33. G. Cossu, C. Ledent, L. Fattore, A. Imperato, G.A. Bohme, and M. Parmentier Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse Behav. Brain Res. 118 2001 61 65
34. J.E. Gallate, T. Saharov, P.E. Mallet, and I.S. McGregor Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist Eur. J. Pharmacol. 370 1999 233 240
35. V. Deroche-Gamonet, M. Le Moal, P.V. Piazza, and P. Soubrie SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats Psychopharmacology (Berl) 157 2001 254 259
36. B.L. Hungund, I. Szakall, A. Adam, B.S. Basavarajappa, and C. Vadasz Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens J. Neurochem. 84 2003 698 704
37. J.N. Crawley, R.L. Corwin, J.K. Robinson, C.C. Felder, W.A. Devane, and J. Axelrod Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents Pharmacol. Biochem. Behav. 46 1993 967 972